Structure

Physi-Chem Properties

Molecular Weight:  549.2
Volume:  539.841
LogP:  5.419
LogD:  3.324
LogS:  -4.598
# Rotatable Bonds:  4
TPSA:  154.23
# H-Bond Aceptor:  10
# H-Bond Donor:  5
# Rings:  6
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.164
Synthetic Accessibility Score:  4.712
Fsp3:  0.367
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.061
MDCK Permeability:  1.0507286788197234e-05
Pgp-inhibitor:  0.104
Pgp-substrate:  0.985
Human Intestinal Absorption (HIA):  0.017
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.21

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.008
Plasma Protein Binding (PPB):  94.42005157470703%
Volume Distribution (VD):  0.375
Pgp-substrate:  4.008613586425781%

ADMET: Metabolism

CYP1A2-inhibitor:  0.332
CYP1A2-substrate:  0.132
CYP2C19-inhibitor:  0.064
CYP2C19-substrate:  0.088
CYP2C9-inhibitor:  0.822
CYP2C9-substrate:  0.924
CYP2D6-inhibitor:  0.365
CYP2D6-substrate:  0.167
CYP3A4-inhibitor:  0.106
CYP3A4-substrate:  0.077

ADMET: Excretion

Clearance (CL):  2.258
Half-life (T1/2):  0.414

ADMET: Toxicity

hERG Blockers:  0.01
Human Hepatotoxicity (H-HT):  0.794
Drug-inuced Liver Injury (DILI):  0.971
AMES Toxicity:  0.791
Rat Oral Acute Toxicity:  0.067
Maximum Recommended Daily Dose:  0.993
Skin Sensitization:  0.175
Carcinogencity:  0.967
Eye Corrosion:  0.003
Eye Irritation:  0.13
Respiratory Toxicity:  0.679

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC316368

Natural Product ID:  NPC316368
Common Name*:   Jadomycin L
IUPAC Name:   n.a.
Synonyms:   Jadomycin L
Standard InCHIKey:  WJUCKDQZAWZICN-OTHGIPIRSA-N
Standard InCHI:  InChI=1S/C30H31NO9/c1-12(2)8-17-30(37)40-29-16-9-13(3)10-18(32)22(16)24-25(31(17)29)28(36)23-15(27(24)35)6-5-7-20(23)39-21-11-19(33)26(34)14(4)38-21/h5-7,9-10,12,14,17,19,21,26,29,32-34H,8,11H2,1-4H3/t14-,17-,19+,21-,26-,29-/m0/s1
SMILES:  CC1C(C(CC(O1)OC2=CC=CC3=C2C(=O)C4=C(C3=O)C5=C(C=C(C=C5O)C)C6N4C(C(=O)O6)CC(C)C)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1631685
PubChem CID:   53318487
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001253] Quinolines and derivatives
        • [CHEMONTID:0001908] Benzoquinolines
          • [CHEMONTID:0000100] Phenanthridines and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28993 Streptomyces venezuelae Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[11720530]
NPO28993 Streptomyces venezuelae Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[16724858]
NPO28993 Streptomyces venezuelae Species Streptomycetaceae Bacteria n.a. Guam Island, Pacific Ocean n.a. PMID[21774474]
NPO28993 Streptomyces venezuelae Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[22050382]
NPO28993 Streptomyces venezuelae Species Streptomycetaceae Bacteria n.a. Guam Island, Pacific Ocean n.a. PMID[23164710]
NPO28993 Streptomyces venezuelae Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[26203536]
NPO28993 Streptomyces venezuelae Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC < 1.0 ug.mL-1 PMID[540269]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 8.0 ug.mL-1 PMID[540269]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 16.0 ug.mL-1 PMID[540269]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC < 1.0 ug.mL-1 PMID[540269]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 4.0 ug.mL-1 PMID[540269]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC < 128.0 ug.mL-1 PMID[540269]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC < 128.0 ug.mL-1 PMID[540269]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 16.0 ug.mL-1 PMID[540269]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 0.5 ug.mL-1 PMID[540269]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 1820.0 nM PMID[540270]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 4100.0 nM PMID[540270]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 9300.0 nM PMID[540270]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC316368 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC284236
0.9948 High Similarity NPC321226
0.9948 High Similarity NPC328856
0.9948 High Similarity NPC478047
0.9948 High Similarity NPC180210
0.9948 High Similarity NPC478046
0.9948 High Similarity NPC314914
0.9896 High Similarity NPC478048
0.9796 High Similarity NPC170101
0.8104 Intermediate Similarity NPC315253
0.8088 Intermediate Similarity NPC42286
0.7981 Intermediate Similarity NPC314941
0.7973 Intermediate Similarity NPC316292
0.7943 Intermediate Similarity NPC314946
0.7938 Intermediate Similarity NPC178281
0.7867 Intermediate Similarity NPC315889
0.7857 Intermediate Similarity NPC63470
0.7835 Intermediate Similarity NPC212099
0.7835 Intermediate Similarity NPC101116
0.7835 Intermediate Similarity NPC278329
0.7835 Intermediate Similarity NPC146837
0.7826 Intermediate Similarity NPC313453
0.7793 Intermediate Similarity NPC315914
0.7788 Intermediate Similarity NPC313274
0.7778 Intermediate Similarity NPC215098
0.7778 Intermediate Similarity NPC124302
0.7778 Intermediate Similarity NPC316412
0.7778 Intermediate Similarity NPC46744
0.7778 Intermediate Similarity NPC14622
0.7778 Intermediate Similarity NPC73020
0.7778 Intermediate Similarity NPC70290
0.7778 Intermediate Similarity NPC315351
0.7778 Intermediate Similarity NPC83019
0.7751 Intermediate Similarity NPC316164
0.7729 Intermediate Similarity NPC204580
0.7727 Intermediate Similarity NPC246274
0.7706 Intermediate Similarity NPC313582
0.7703 Intermediate Similarity NPC109403
0.7703 Intermediate Similarity NPC261012
0.7703 Intermediate Similarity NPC226652
0.7703 Intermediate Similarity NPC120671
0.7703 Intermediate Similarity NPC314100
0.7703 Intermediate Similarity NPC314738
0.7703 Intermediate Similarity NPC72788
0.77 Intermediate Similarity NPC203751
0.77 Intermediate Similarity NPC257728
0.77 Intermediate Similarity NPC85368
0.7696 Intermediate Similarity NPC469437
0.7689 Intermediate Similarity NPC80472
0.7685 Intermediate Similarity NPC475161
0.7685 Intermediate Similarity NPC477860
0.7664 Intermediate Similarity NPC153365
0.7662 Intermediate Similarity NPC68381
0.7662 Intermediate Similarity NPC470667
0.7662 Intermediate Similarity NPC223735
0.7662 Intermediate Similarity NPC186800
0.7662 Intermediate Similarity NPC307754
0.7653 Intermediate Similarity NPC257266
0.765 Intermediate Similarity NPC315619
0.763 Intermediate Similarity NPC2173
0.763 Intermediate Similarity NPC202771
0.763 Intermediate Similarity NPC328700
0.763 Intermediate Similarity NPC119818
0.7624 Intermediate Similarity NPC102053
0.7624 Intermediate Similarity NPC76112
0.7624 Intermediate Similarity NPC92403
0.7624 Intermediate Similarity NPC475246
0.7624 Intermediate Similarity NPC66820
0.7624 Intermediate Similarity NPC289876
0.7624 Intermediate Similarity NPC475233
0.7624 Intermediate Similarity NPC170018
0.7613 Intermediate Similarity NPC252156
0.7612 Intermediate Similarity NPC199357
0.7596 Intermediate Similarity NPC33256
0.7574 Intermediate Similarity NPC3718
0.757 Intermediate Similarity NPC314596
0.7563 Intermediate Similarity NPC97637
0.7563 Intermediate Similarity NPC187934
0.7563 Intermediate Similarity NPC216752
0.7562 Intermediate Similarity NPC30432
0.7562 Intermediate Similarity NPC271385
0.7562 Intermediate Similarity NPC111536
0.7562 Intermediate Similarity NPC76128
0.7562 Intermediate Similarity NPC5029
0.755 Intermediate Similarity NPC191653
0.7549 Intermediate Similarity NPC277710
0.7549 Intermediate Similarity NPC153578
0.7549 Intermediate Similarity NPC299149
0.7549 Intermediate Similarity NPC114257
0.7549 Intermediate Similarity NPC58538
0.7537 Intermediate Similarity NPC198893
0.7537 Intermediate Similarity NPC232818
0.7537 Intermediate Similarity NPC46958
0.7537 Intermediate Similarity NPC314489
0.7536 Intermediate Similarity NPC105591
0.7536 Intermediate Similarity NPC226708
0.7525 Intermediate Similarity NPC98776
0.7524 Intermediate Similarity NPC166979
0.7512 Intermediate Similarity NPC298778
0.7512 Intermediate Similarity NPC197357
0.7512 Intermediate Similarity NPC85316
0.75 Intermediate Similarity NPC185031
0.75 Intermediate Similarity NPC205721
0.7488 Intermediate Similarity NPC199533
0.7488 Intermediate Similarity NPC470454
0.7488 Intermediate Similarity NPC63105
0.7488 Intermediate Similarity NPC474345
0.7487 Intermediate Similarity NPC148323
0.7487 Intermediate Similarity NPC283480
0.7465 Intermediate Similarity NPC286135
0.7464 Intermediate Similarity NPC314672
0.7463 Intermediate Similarity NPC222455
0.7463 Intermediate Similarity NPC245059
0.7463 Intermediate Similarity NPC259905
0.7463 Intermediate Similarity NPC84494
0.7449 Intermediate Similarity NPC208651
0.7449 Intermediate Similarity NPC206641
0.744 Intermediate Similarity NPC224557
0.744 Intermediate Similarity NPC292706
0.7438 Intermediate Similarity NPC213052
0.7438 Intermediate Similarity NPC309692
0.7438 Intermediate Similarity NPC472054
0.7437 Intermediate Similarity NPC17432
0.7436 Intermediate Similarity NPC192219
0.7436 Intermediate Similarity NPC82190
0.7436 Intermediate Similarity NPC174599
0.7427 Intermediate Similarity NPC18306
0.7427 Intermediate Similarity NPC470448
0.7427 Intermediate Similarity NPC470452
0.7427 Intermediate Similarity NPC164047
0.7427 Intermediate Similarity NPC470453
0.7416 Intermediate Similarity NPC94499
0.7412 Intermediate Similarity NPC211215
0.7411 Intermediate Similarity NPC53139
0.7406 Intermediate Similarity NPC267414
0.7406 Intermediate Similarity NPC478045
0.7406 Intermediate Similarity NPC207239
0.7404 Intermediate Similarity NPC87583
0.74 Intermediate Similarity NPC478022
0.74 Intermediate Similarity NPC478020
0.74 Intermediate Similarity NPC99216
0.74 Intermediate Similarity NPC478026
0.7391 Intermediate Similarity NPC478001
0.7391 Intermediate Similarity NPC473631
0.7391 Intermediate Similarity NPC473717
0.7391 Intermediate Similarity NPC475662
0.7391 Intermediate Similarity NPC162694
0.7391 Intermediate Similarity NPC293227
0.7389 Intermediate Similarity NPC478002
0.7385 Intermediate Similarity NPC209393
0.7385 Intermediate Similarity NPC205172
0.7381 Intermediate Similarity NPC469816
0.7381 Intermediate Similarity NPC469815
0.7379 Intermediate Similarity NPC212290
0.7374 Intermediate Similarity NPC328093
0.7371 Intermediate Similarity NPC108487
0.7366 Intermediate Similarity NPC312630
0.7366 Intermediate Similarity NPC324220
0.7363 Intermediate Similarity NPC178851
0.736 Intermediate Similarity NPC29552
0.736 Intermediate Similarity NPC177742
0.7358 Intermediate Similarity NPC314020
0.7347 Intermediate Similarity NPC3449
0.7346 Intermediate Similarity NPC308895
0.7346 Intermediate Similarity NPC48474
0.7339 Intermediate Similarity NPC46990
0.733 Intermediate Similarity NPC478000
0.7321 Intermediate Similarity NPC475352
0.7321 Intermediate Similarity NPC475220
0.7321 Intermediate Similarity NPC473686
0.7321 Intermediate Similarity NPC229817
0.7321 Intermediate Similarity NPC241847
0.7321 Intermediate Similarity NPC221140
0.7317 Intermediate Similarity NPC146803
0.7317 Intermediate Similarity NPC193377
0.7313 Intermediate Similarity NPC474301
0.7311 Intermediate Similarity NPC24228
0.7304 Intermediate Similarity NPC183441
0.7302 Intermediate Similarity NPC131405
0.73 Intermediate Similarity NPC22324
0.7296 Intermediate Similarity NPC470331
0.7296 Intermediate Similarity NPC185103
0.7295 Intermediate Similarity NPC474746
0.7295 Intermediate Similarity NPC475981
0.7291 Intermediate Similarity NPC473202
0.729 Intermediate Similarity NPC133775
0.7286 Intermediate Similarity NPC174486
0.7282 Intermediate Similarity NPC475054
0.7273 Intermediate Similarity NPC106700
0.7273 Intermediate Similarity NPC141440
0.7268 Intermediate Similarity NPC316539
0.7264 Intermediate Similarity NPC477258
0.7264 Intermediate Similarity NPC125924
0.726 Intermediate Similarity NPC170203
0.726 Intermediate Similarity NPC315221
0.7257 Intermediate Similarity NPC148124
0.7255 Intermediate Similarity NPC477573
0.7255 Intermediate Similarity NPC76047
0.7255 Intermediate Similarity NPC478021
0.7255 Intermediate Similarity NPC52598

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC316368 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8093 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.8038 Intermediate Similarity NPD7701 Phase 2
0.7981 Intermediate Similarity NPD8319 Approved
0.7981 Intermediate Similarity NPD8320 Phase 1
0.7778 Intermediate Similarity NPD4420 Approved
0.7736 Intermediate Similarity NPD7584 Approved
0.7703 Intermediate Similarity NPD6782 Approved
0.7703 Intermediate Similarity NPD6778 Approved
0.7703 Intermediate Similarity NPD6777 Approved
0.7703 Intermediate Similarity NPD6776 Approved
0.7703 Intermediate Similarity NPD6781 Approved
0.7703 Intermediate Similarity NPD6779 Approved
0.7703 Intermediate Similarity NPD6780 Approved
0.77 Intermediate Similarity NPD7585 Approved
0.7674 Intermediate Similarity NPD7783 Phase 2
0.7674 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7653 Intermediate Similarity NPD7583 Approved
0.763 Intermediate Similarity NPD5005 Approved
0.763 Intermediate Similarity NPD5006 Approved
0.7628 Intermediate Similarity NPD7874 Approved
0.7628 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD8312 Approved
0.7624 Intermediate Similarity NPD8313 Approved
0.7613 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7594 Intermediate Similarity NPD7696 Phase 3
0.7594 Intermediate Similarity NPD7698 Approved
0.7594 Intermediate Similarity NPD7697 Approved
0.7581 Intermediate Similarity NPD8151 Discontinued
0.7574 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7573 Intermediate Similarity NPD3808 Clinical (unspecified phase)
0.7569 Intermediate Similarity NPD7930 Approved
0.7559 Intermediate Similarity NPD7871 Phase 2
0.7559 Intermediate Similarity NPD7870 Phase 2
0.7512 Intermediate Similarity NPD7801 Approved
0.7511 Intermediate Similarity NPD8059 Phase 3
0.7511 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7488 Intermediate Similarity NPD8285 Discontinued
0.7465 Intermediate Similarity NPD6823 Phase 2
0.7464 Intermediate Similarity NPD6535 Approved
0.7464 Intermediate Similarity NPD6534 Approved
0.7442 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD7435 Discontinued
0.7421 Intermediate Similarity NPD8404 Phase 2
0.7416 Intermediate Similarity NPD6212 Phase 3
0.7416 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7416 Intermediate Similarity NPD6213 Phase 3
0.7368 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD7999 Approved
0.7358 Intermediate Similarity NPD7700 Phase 2
0.7358 Intermediate Similarity NPD7699 Phase 2
0.7356 Intermediate Similarity NPD7235 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD7565 Approved
0.7313 Intermediate Similarity NPD8491 Approved
0.7289 Intermediate Similarity NPD8366 Approved
0.7273 Intermediate Similarity NPD8461 Discontinued
0.7268 Intermediate Similarity NPD6559 Discontinued
0.7257 Intermediate Similarity NPD6997 Phase 2
0.7241 Intermediate Similarity NPD7177 Discontinued
0.7214 Intermediate Similarity NPD5711 Approved
0.7214 Intermediate Similarity NPD5710 Approved
0.7209 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD8469 Approved
0.7183 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7183 Intermediate Similarity NPD4361 Phase 2
0.7183 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD7048 Phase 3
0.7163 Intermediate Similarity NPD6874 Approved
0.7137 Intermediate Similarity NPD7907 Approved
0.7124 Intermediate Similarity NPD4665 Approved
0.7124 Intermediate Similarity NPD4111 Phase 1
0.7107 Intermediate Similarity NPD5889 Approved
0.7107 Intermediate Similarity NPD5890 Approved
0.71 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD8150 Discontinued
0.7091 Intermediate Similarity NPD6973 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD7810 Phase 3
0.7083 Intermediate Similarity NPD7811 Phase 3
0.7073 Intermediate Similarity NPD3818 Discontinued
0.7073 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD6844 Discontinued
0.707 Intermediate Similarity NPD7238 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD4360 Phase 2
0.7056 Intermediate Similarity NPD4363 Phase 3
0.704 Intermediate Similarity NPD5676 Approved
0.7039 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7028 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD3450 Approved
0.7018 Intermediate Similarity NPD3452 Approved
0.7018 Intermediate Similarity NPD2493 Approved
0.7018 Intermediate Similarity NPD2494 Approved
0.7015 Intermediate Similarity NPD8005 Clinical (unspecified phase)
0.7014 Intermediate Similarity NPD3863 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD3226 Approved
0.7 Intermediate Similarity NPD4582 Approved
0.7 Intermediate Similarity NPD4583 Approved
0.6986 Remote Similarity NPD5034 Approved
0.6986 Remote Similarity NPD4954 Approved
0.6986 Remote Similarity NPD3057 Approved
0.6986 Remote Similarity NPD5026 Approved
0.6986 Remote Similarity NPD4955 Approved
0.6986 Remote Similarity NPD5028 Approved
0.6986 Remote Similarity NPD36 Approved
0.6979 Remote Similarity NPD6625 Approved
0.6976 Remote Similarity NPD3451 Clinical (unspecified phase)
0.697 Remote Similarity NPD6585 Discontinued
0.6966 Remote Similarity NPD8067 Phase 3
0.6957 Remote Similarity NPD3050 Clinical (unspecified phase)
0.6957 Remote Similarity NPD7054 Approved
0.6955 Remote Similarity NPD4004 Approved
0.6955 Remote Similarity NPD4002 Approved
0.6955 Remote Similarity NPD8152 Approved
0.6955 Remote Similarity NPD8153 Approved
0.6946 Remote Similarity NPD4666 Phase 3
0.6943 Remote Similarity NPD5433 Clinical (unspecified phase)
0.6942 Remote Similarity NPD3446 Phase 1
0.6938 Remote Similarity NPD5030 Phase 2
0.6934 Remote Similarity NPD5038 Approved
0.6934 Remote Similarity NPD5037 Approved
0.6927 Remote Similarity NPD5242 Approved
0.6923 Remote Similarity NPD7074 Phase 3
0.6923 Remote Similarity NPD7472 Approved
0.6912 Remote Similarity NPD2974 Approved
0.6912 Remote Similarity NPD2975 Approved
0.6912 Remote Similarity NPD2973 Approved
0.6909 Remote Similarity NPD2972 Approved
0.6909 Remote Similarity NPD2491 Approved
0.6909 Remote Similarity NPD3448 Approved
0.6909 Remote Similarity NPD3533 Approved
0.6905 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6897 Remote Similarity NPD5709 Phase 3
0.6895 Remote Similarity NPD4580 Approved
0.6895 Remote Similarity NPD4107 Approved
0.6895 Remote Similarity NPD5457 Discontinued
0.6892 Remote Similarity NPD8161 Suspended
0.689 Remote Similarity NPD6797 Phase 2
0.689 Remote Similarity NPD3823 Discontinued
0.6887 Remote Similarity NPD5036 Approved
0.6878 Remote Similarity NPD7597 Clinical (unspecified phase)
0.6869 Remote Similarity NPD8361 Approved
0.6869 Remote Similarity NPD8360 Approved
0.6857 Remote Similarity NPD7039 Approved
0.6857 Remote Similarity NPD7251 Discontinued
0.6857 Remote Similarity NPD7038 Approved
0.6853 Remote Similarity NPD6090 Discontinued
0.6842 Remote Similarity NPD7047 Phase 3
0.6842 Remote Similarity NPD8492 Approved
0.6837 Remote Similarity NPD2490 Approved
0.6837 Remote Similarity NPD2488 Approved
0.6834 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6833 Remote Similarity NPD6863 Phase 2
0.6832 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6825 Remote Similarity NPD7808 Phase 3
0.6816 Remote Similarity NPD8367 Approved
0.6812 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6806 Remote Similarity NPD5968 Phase 3
0.6806 Remote Similarity NPD7296 Approved
0.68 Remote Similarity NPD4380 Phase 2
0.6795 Remote Similarity NPD7186 Phase 3
0.6791 Remote Similarity NPD6836 Approved
0.6791 Remote Similarity NPD8435 Approved
0.6788 Remote Similarity NPD2346 Discontinued
0.6787 Remote Similarity NPD4482 Phase 3
0.6787 Remote Similarity NPD7566 Clinical (unspecified phase)
0.6782 Remote Similarity NPD7819 Suspended
0.6779 Remote Similarity NPD7473 Discontinued
0.6766 Remote Similarity NPD6386 Approved
0.6766 Remote Similarity NPD6385 Approved
0.6765 Remote Similarity NPD7075 Discontinued
0.6761 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6757 Remote Similarity NPD8163 Clinical (unspecified phase)
0.6757 Remote Similarity NPD8162 Phase 2
0.6756 Remote Similarity NPD6593 Clinical (unspecified phase)
0.675 Remote Similarity NPD2651 Approved
0.675 Remote Similarity NPD2649 Approved
0.6749 Remote Similarity NPD5402 Approved
0.6748 Remote Similarity NPD6959 Discontinued
0.6746 Remote Similarity NPD7228 Approved
0.6742 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6735 Remote Similarity NPD3295 Clinical (unspecified phase)
0.6731 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6715 Remote Similarity NPD6808 Phase 2
0.6715 Remote Similarity NPD6232 Discontinued
0.6714 Remote Similarity NPD5844 Phase 1
0.6712 Remote Similarity NPD7476 Discontinued
0.6711 Remote Similarity NPD7827 Phase 1
0.6698 Remote Similarity NPD5031 Approved
0.6698 Remote Similarity NPD8434 Phase 2
0.6698 Remote Similarity NPD5029 Approved
0.6698 Remote Similarity NPD5027 Approved
0.6698 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6683 Remote Similarity NPD2970 Approved
0.6683 Remote Similarity NPD2969 Approved
0.6682 Remote Similarity NPD5441 Clinical (unspecified phase)
0.6681 Remote Similarity NPD4859 Phase 1
0.6667 Remote Similarity NPD7256 Discontinued
0.6667 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5978 Approved
0.6667 Remote Similarity NPD5977 Approved
0.6667 Remote Similarity NPD7906 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data